These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 33120225)

  • 1. Evolution of resistance to fluoroquinolones by dengue virus serotype 4 provides insight into mechanism of action and consequences for viral fitness.
    Scroggs SLP; Gass JT; Chinnasamy R; Widen SG; Azar SR; Rossi SL; Arterburn JB; Vasilakis N; Hanley KA
    Virology; 2021 Jan; 552():94-106. PubMed ID: 33120225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Old Drugs with New Tricks: Efficacy of Fluoroquinolones to Suppress Replication of Flaviviruses.
    Scroggs SLP; Andrade CC; Chinnasamy R; Azar SR; Schirtzinger EE; Garcia EI; Arterburn JB; Hanley KA; Rossi SL
    Viruses; 2020 Sep; 12(9):. PubMed ID: 32933138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of the natural alkaloid anisomycin against dengue and Zika viruses.
    Quintana VM; Selisko B; Brunetti JE; Eydoux C; Guillemot JC; Canard B; Damonte EB; Julander JG; Castilla V
    Antiviral Res; 2020 Apr; 176():104749. PubMed ID: 32081740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolone Antibiotics Exhibit Low Antiviral Activity against SARS-CoV-2 and MERS-CoV.
    Scroggs SLP; Offerdahl DK; Flather DP; Morris CN; Kendall BL; Broeckel RM; Beare PA; Bloom ME
    Viruses; 2020 Dec; 13(1):. PubMed ID: 33374514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BIKE regulates dengue virus infection and is a cellular target for broad-spectrum antivirals.
    Pu S; Schor S; Karim M; Saul S; Robinson M; Kumar S; Prugar LI; Dorosky DE; Brannan J; Dye JM; Einav S
    Antiviral Res; 2020 Dec; 184():104966. PubMed ID: 33137362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carnosine exhibits significant antiviral activity against Dengue and Zika virus.
    Rothan HA; Abdulrahman AY; Khazali AS; Nor Rashid N; Chong TT; Yusof R
    J Pept Sci; 2019 Aug; 25(8):e3196. PubMed ID: 31290226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dengue Virus Evolution under a Host-Targeted Antiviral.
    Plummer E; Buck MD; Sanchez M; Greenbaum JA; Turner J; Grewal R; Klose B; Sampath A; Warfield KL; Peters B; Ramstedt U; Shresta S
    J Virol; 2015 May; 89(10):5592-601. PubMed ID: 25762732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of in vitro dengue virus resistance to carrageenan.
    Talarico LB; Damonte EB
    J Med Virol; 2016 Jul; 88(7):1120-9. PubMed ID: 26694200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral Activity of Compound L3 against Dengue and Zika Viruses In Vitro and In Vivo.
    Chuang FK; Liao CL; Hu MK; Chiu YL; Lee AR; Huang SM; Chiu YL; Tsai PL; Su BC; Chang TH; Lin CC; Shih CC; Yen LC
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral Evaluation of UV-4B and Interferon-Alpha Combination Regimens against Dengue Virus.
    Franco EJ; Pires de Mello CP; Brown AN
    Viruses; 2021 Apr; 13(5):. PubMed ID: 33925551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mosquitoes put the brake on arbovirus evolution: experimental evolution reveals slower mutation accumulation in mosquito than vertebrate cells.
    Vasilakis N; Deardorff ER; Kenney JL; Rossi SL; Hanley KA; Weaver SC
    PLoS Pathog; 2009 Jun; 5(6):e1000467. PubMed ID: 19503824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry.
    Kuo YT; Liu CH; Li JW; Lin CJ; Jassey A; Wu HN; Perng GC; Yen MH; Lin LT
    Sci Rep; 2020 Oct; 10(1):16378. PubMed ID: 33009425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-dengue virus serotype 2 activity and mode of action of a novel peptide.
    Chew MF; Tham HW; Rajik M; Sharifah SH
    J Appl Microbiol; 2015 Oct; 119(4):1170-80. PubMed ID: 26248692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in antiviral susceptibility to entry inhibitors and endocytic uptake of dengue-2 virus serially passaged in Vero or C6/36 cells.
    Acosta EG; Piccini LE; Talarico LB; Castilla V; Damonte EB
    Virus Res; 2014 May; 184():39-43. PubMed ID: 24583230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A small molecule inhibitor of ER-to-cytosol protein dislocation exhibits anti-dengue and anti-Zika virus activity.
    Ruan J; Rothan HA; Zhong Y; Yan W; Henderson MJ; Chen F; Fang S
    Sci Rep; 2019 Jul; 9(1):10901. PubMed ID: 31358863
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Haddad JG; Koishi AC; Gaudry A; Nunes Duarte Dos Santos C; Viranaicken W; Desprès P; El Kalamouni C
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31091703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labyrinthopeptin A1 inhibits dengue and Zika virus infection by interfering with the viral phospholipid membrane.
    Oeyen M; Meyen E; Noppen S; Claes S; Doijen J; Vermeire K; Süssmuth RD; Schols D
    Virology; 2021 Oct; 562():74-86. PubMed ID: 34274562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of dengue virus through suppression of host pyrimidine biosynthesis.
    Wang QY; Bushell S; Qing M; Xu HY; Bonavia A; Nunes S; Zhou J; Poh MK; Florez de Sessions P; Niyomrattanakit P; Dong H; Hoffmaster K; Goh A; Nilar S; Schul W; Jones S; Kramer L; Compton T; Shi PY
    J Virol; 2011 Jul; 85(13):6548-56. PubMed ID: 21507975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of dengue virus resistance to brequinar in cell culture.
    Qing M; Zou G; Wang QY; Xu HY; Dong H; Yuan Z; Shi PY
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3686-95. PubMed ID: 20606073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
    Hernandez-Morales I; Geluykens P; Clynhens M; Strijbos R; Goethals O; Megens S; Verheyen N; Last S; McGowan D; Coesemans E; De Boeck B; Stoops B; Devogelaere B; Pauwels F; Vandyck K; Berke JM; Raboisson P; Simmen K; Lory P; Van Loock M
    Antiviral Res; 2017 Nov; 147():149-158. PubMed ID: 29037976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.